NetworkNewsBreaks

FridayMar 26, 2021 9:26 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2020 Financial, Operational Results

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), reported is financial and operational results for the fourth quarter and fiscal year ending Dec. 31, 2020. The company also held a conference call on March 25, 2021, to discuss the new report. High on the list of significant achievements for the company was a full-year revenue increase of 15%; revenue for 2020 was $13.1 million compared to $11.4 million in 2019. Gross profit and margin was up for both the fourth quarter and…

Continue Reading

ThursdayMar 25, 2021 3:22 pm

NetworkNewsBreaks – Knightscope Inc. Reaches +21K Investor Mark

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it now has more than 21,000 investors. The update reads, “It is indeed a great honor to announce that in a short amount of time we've added another 1,000+ investors backing our efforts to better secure the USA! We are also honored to share a quote from one of our investors we thought you would find interesting: ‘Knightscope’s Autonomous Data Machines are as much a force multiplier and critical resource as any of the cutting-edge SWAT equipment that I acquired and deployed…

Continue Reading

ThursdayMar 25, 2021 2:49 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces 2nd Major DSD Expansion

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) today announced its latest partnership with Nevada Beverage Company, a Nevada-based direct-store-delivery (“DSD”) distributor. Under the agreement, Nevada Beverage will carry WTER’s full line of smooth-tasting Alkaline88 and A88 Infused flavored waters. “We are pleased to welcome Nevada Beverage Company to our growing DSD network. Nevada Beverage is a leading beverage distributor in Nevada, serving over 2,900 accounts with a territory encompassing 74% of the state population. As a best-in-class DSD provider, the partnership allows our waters to inundate another important market in the Southwest,” said Ricky Wright, president and CEO of…

Continue Reading

ThursdayMar 25, 2021 2:14 pm

NetworkNewsBreaks – Hollywall Entertainment Inc. (HWAL) Completes Two-Year Audit

Hollywall Entertainment (OTC: HWAL), a telecommunication, infrastructure, media, technology, broadcasting and entertainment company, has announced the completion of the U.S. Public Company Accounting Oversight Board (“PCAOB”) audited financial statements for fiscal years ending in Dec. 31, 2019, and Dec. 31, 2018. The audits were conducted by Accell Audit and Compliance P.A., which is an independent registered public accounting firm that operates within the jurisdiction of the federal securities laws administered by the Securities and Exchange Commission (“SEC”). In March of last year, HWAL retained Accell to conduct a complete audit of the company in compliance with SEC Rule 3520. The completed…

Continue Reading

ThursdayMar 25, 2021 2:13 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Continues to Advance Toward Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that the Wroclaw, Poland-based Lower Silesian Medical Chamber Ethics Committee gave WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) (“WPD”), the company’s sublicensee in Europe and Asia for its lead drug candidate, Berubicin, a positive opinion for its WPD-201 Clinical Trial Protocol. The protocol will be used in the planned forthcoming Berubicin clinical trial in adults with glioblastoma multiforme (“GBM”). This new development set the wheels in motion for the eventual approval of WPD’s studies — a multicenter Berubicin Phase 2 adult GBM trial and a multicenter pediatric Phase 1 malignant glioma trial. “WPD plans to…

Continue Reading

ThursdayMar 25, 2021 1:43 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Clarifies Donation to US Charity Giving Hope as Personal Gift from CEO

PowerBand Solutions (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a comprehensive e-commerce solution transforming the online experience to sell, trade, lease, and finance vehicles, today clarified that the donation (1,000,000 PBX shares) to Giving HOPE, the New Orleans-based charity, is a personal gift from PowerBand CEO Kelly Jennings. "My donation has no impact on the treasury of PowerBand nor does it dilute the company in any way," said Jennings. "We wanted to make that clear to our shareholders." The donation allows Giving HOPE the ability to redirect other funds to build HOPE House orphanages, one of Giving HOPE's several humanitarian undertakings.…

Continue Reading

ThursdayMar 25, 2021 1:39 pm

NetworkNewsBreaks – Mobius Interactive Ltd. Looks to Bright Future in Gaming Industry, Backed by New Technologies

Mobius Interactive, an online gaming operator featuring unique offerings for diverse demographic groups, is excited about the potential benefits of the new technologies being integrated into the gaming industry. In an interview with G&M News, Mobius Interactive’s co-founder and COO Robin Lawson discussed “significant changes in the online gaming community, from unprecedented growth during 2020 due to the pandemic and lockdowns to the use of blockchain and bitcoin in the gaming industry.” The article reporting the interview quotes Lawson as saying, “We are seeing improved payments on betting with cryptocurrencies like bitcoin, which is one of a number of crypto…

Continue Reading

ThursdayMar 25, 2021 1:30 pm

NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL), Bidi Welcome Category Reform in China

Kaival Brands Innovations Group (KAVL), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, has noted recent news from China outlining increased supervision over the e-cigarette category. KAVL, which is the exclusive global distributor of all products manufactured by Bidi Vapor LLC, welcomes the news, particularly as it pertains the BIDI(R) Stick disposable electronic nicotine delivery system (“ENDS”). The company noted that the expanding government regulations align with Kaival Brands' dedicated and thorough efforts to maintain standards of compliance and quality. Kaival Brands and Bidi Vapor observed that the additional supervision of e-cigarette manufacturing should…

Continue Reading

ThursdayMar 25, 2021 1:15 pm

NetworkNewsBreaks – Healthy Extracts Inc. (HYEX) Achieves Strong Growth Amid Booming Market

Healthy Extracts (OTCQB: HYEX), a leading developer and manufacturer of heart health, brain health and supplementary technologies, reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 over the 12 months ending December 31, 2020. The company attributes this growth to the transition to its new business selling health nutrition products, which positions HYEX for opportunity in the booming plant-based foods and products industry projected to reach $74.2 billion in 2027. “We changed our name from Grey Cloak Tech Inc. to Healthy Extracts Inc. to more accurately reflect our business,” a recent article quotes Kevin Duke Pitts, director,…

Continue Reading

ThursdayMar 25, 2021 1:14 pm

NetworkNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Completion of Pilot Trial, Releases White Paper

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has completed a pilot study assessing the effect of its HempFusion formulation CBD Capsules(R) (HempFusion 20mg CBD capsules with botanical terpenes) as it relates to a combination of anti-inflammatories in lowering the results of the chronic inflammation test. The study was conducted in collaboration with Kansas-based Inflammatory Markers Laboratory (“IML”). In addition, the company also released a white paper titled, “Oral Formulation May Modulate Thromboxane Production.” The white paper was s co-authored by IML director Gordon Ens and…

Continue Reading